Subsequently, they delivered a NIR light-responsive hydrogel system (HMI@GEL) after loading metformin (Met) to block the energy supply of the tumor and catalase-mimicking Hemin@mil88 to effectively alleviate tumor hypoxia. This evidence concerns the gene CAT and neoplasm.